Application 216048
- Type
- ANDA
- Sponsor
- CIPLA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MIDAZOLAM | MIDAZOLAM | SPRAY;NASAL | 5MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Midazolam | MIDAZOLAM HYDROCHLORIDE | SOMERSET THERAPEUTICS, LLC | 06e4f754-72df-4eb4-aaed-b538524f5277 | 2023-12-05 | Boxed warning, Warnings, Adverse reactions | Midazolam |
| midazolam | MIDAZOLAM HYDROCHLORIDE | Sagent Pharmaceuticals | 880cac48-5c0f-49a9-8aef-3c9770bf5d84 | 2023-11-03 | Boxed warning, Warnings, Adverse reactions | midazolam |
| midazolam | MIDAZOLAM HYDROCHLORIDE | Sagent Pharmaceuticals | e22611dd-1830-40af-9139-7cdb07f5a426 | 2023-11-03 | Boxed warning, Warnings, Adverse reactions | midazolam |
| Midazolam | MIDAZOLAM | Micro Labs Limited | 9221894f-d840-46f2-a11c-6b71358d3b5b | 2023-08-24 | Boxed warning, Warnings, Adverse reactions | Midazolam MIDAZOLAM |
| Nayzilam | MIDAZOLAM | UCB, Inc. | 2b29422e-54d5-4a49-8522-e9cf752368c3 | 2023-01-19 | Boxed warning, Warnings, Adverse reactions | MIDAZOLAM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 72936 | ORIG | 2022-12-20 |